IL21 and peripheral arterial disease: With little to no data available on the IL21/IL21R pathway in PAD, we performed RNA sequencing (RNA-Seq)-based analysis of whole transcriptomes from ischemic muscle with or without IL-21/IL-21R-pathway interruption, using a soluble IL-21R-Fc chimera as described [10].